Background: rnHodgkin lymphoma (HL) exhibits considerable clinico pathological variations in different partsrnof the world. This study was prompted by the limited availability of HL data in developingrncountries (particularly long-term outcomes). rn rnMethodology: rnThis is hospital based retrospective study of 96 patients diagnosed and treated with HL at TASH,rnfrom December 2010 to December 2015, at department of internal medicine, hematology unit.rnPatient records and phone interviewing was used to collect data. rnResults: rnThe study included 96 patients with a median age of 24 years (range14â€“60 years); 58% ofrnpatients were between ages 14-25. 71 % were male, male to female ratio of 2.4. The mostrncommon primary presentation was peripheral lymphadenopathy (93%), the neck lymph nodesrnwere primary complaints in 75% of patients. B symptoms occurred in 63% .71% had anrnadvanced stage, 25% had bulky disease. Mixed Cellularity was the most common histologicalrnsubtype (52%). Initial therapy outcomes were complete response, progressive disease, partialrnresponse, and in 84%, 8%, and 7% of patients, respectively. The mean follow up patients fromrnpatient records was 12 months, from phone interviews 36 months. The 5 year overall survivalrn(OS) 81%., and progression free survival (PFS) was and 70%.Multivariate analysis showed thatrntreatment discontinuation was independently associated with death. rn rnConclusion: rnHodgkinâ€™s Lymphoma follows epidemiological and clinical features of developing countries atrnour center. The 5-year overall and progression-free survivals were below international rates.rnTreatment adherence significantly contributes to overall survival.